Integrating Metal-Organic Frameworks with Antimicrobial Peptides: Advances and Challenges in Antibacterial

Yuxuan Sun1, Hanyu Zhong1, Yueqing Wang1

  • 1State Key Laboratory of Oral Diseases, National Clinical Research Center for Oral Diseases, Department of Prosthodontics, West China Hospital of Stomatology, Sichuan University, Chengdu 610041, China.

ACS Omega
|February 23, 2026
PubMed

Insights

Antimicrobial peptides (AMPs) show promise against resistant bacteria but degrade easily. Combining AMPs with Metal-Organic Frameworks (MOFs) creates drug-delivery systems that protect AMPs, enhancing their antimicrobial efficacy.

Area of Science:

  • Biomaterials Science
  • Nanotechnology
  • Drug Delivery Systems

Background:

  • Antibiotic resistance is a major global health threat.
  • Antimicrobial peptides (AMPs) offer an alternative but face challenges like degradation and toxicity.
  • Metal-Organic Frameworks (MOFs) are promising biocompatible carriers with tunable properties.

Purpose of the Study:

  • To review the synergistic potential of AMPs@MOF drug-delivery systems.
  • To explore the design, applications, and antimicrobial mechanisms of AMPs@MOF systems.
  • To highlight AMPs@MOF as a novel strategy for combating drug-resistant pathogens.

Main Methods:

  • Review of existing literature on AMPs and MOFs.
  • Analysis of AMPs@MOF system design principles.
  • Examination of antimicrobial mechanisms and therapeutic applications.

Main Results:

  • MOFs protect AMPs from degradation, enhance targeted delivery, and allow controlled release.
  • AMPs@MOF systems demonstrate efficacy against drug-resistant pathogens.
  • These hybrid systems disrupt bacterial membranes, inhibit protein synthesis, and modulate immune responses.

Conclusions:

  • AMPs@MOF systems represent a novel and effective approach for developing advanced antimicrobial therapies.
  • This hybrid strategy addresses the limitations of traditional antibiotics and AMPs.
  • Further research into AMPs@MOF systems holds significant potential for future antimicrobial drug development.